QA: Orgenesis Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2021_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 50,077,000
1 IntangibleAssetsNetIncludingGoodwill 21,768,000
2 PropertyPlantAndEquipmentNet 3,073,000
3 remainder_Assets 2,766,000
4 LiabilitiesCurrent 16,285,000
5 LiabilitiesNoncurrent 8,671,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 16,285,045
8 SellingGeneralAndAdministrativeExpense 16,666,454
9 ResearchAndDevelopmentExpense 441,010,952
10 remainder_Expenses 2,134,849
11 remainder_Revenues 14,266,962
12 remainder_NetIncome -1,404,757
13 remainder_ComprehensiveNetIncome 136,657
  yvar yval
0 Assets 77,684,000
1 Liabilities 24,956,000
2 Expenses 476,097,300
3 Revenues 14,266,962
4 StockholdersEquity 52,728,000
5 NetIncome -463,235,095
6 ComprehensiveNetIncome -463,166,766
7 BaseVar 297,272,838
8 EconomicCapitalRatiobeforeLimitedLiability -6.79
9 EconomicCapitalRatio 0.0355

Edgar->Model Mapping

Feature Distribution

Change over Time